LIONNS-D2 trial medicines for Cardiff University handled by Simbec-Orion
- Cardiff University
- Wales
- Competitive flexible procedure, 3 bids
- 5 October 2026 to 1 October 2027
Cardiff University hired Simbec-Orion Group Ltd to import, pack and deliver the medicines for LIONNS-D2, a clinical trial led by its School of Medicine.
A UKRI grant funds the trial, which tests a new medicine called triiodothyronine sulphate (T3S). Its subjects have an underactive thyroid and a gene difference affecting the deiodinase 2 enzyme. Simbec-Orion brings in the T3S tablets, which Ardena makes in Spain, and prepares them with a second trial medicine, L-thyroxine, for the trial pharmacy at Royal Glamorgan Hospital.
Quality counted for 60% of the score, price for 30% and responsible procurement for 10%. Three bids came in, and Simbec-Orion won in September 2026 at £212,473, less than half the £452,168 estimate. The contract runs to October 2027.
Contract ends October 2027
- What
- Aseptic compounding, specials and contract pharmaceutical manufacturing
- Buyer
- Cardiff University
- Supplier
- Simbec-Orion Group Ltd
- Value
- £212,473
- How it was bought
- Competitive flexible procedure
- 3 bids
- Dates and next
- Oct 2026 to Oct 2027